Skip to content

The effects of drugs on the pain after Lithotripsy

Evaluation the effect of pethidine and midazolam versus propofol and fentanyl on pain control during extracorporeal shock wave lithotripsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016051427893N1
Enrollment
75
Registered
2016-11-24
Start date
2016-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone. Calculus of kidney

Interventions

Intervention 1: First group will receive Intravenous Pethidine and midazolam (20 to 40 milligram pethidine and 1 to 2 milligram midazolam) before beginning extracorporeal shock wave lithotripsy. Inter
Treatment - Drugs
First group will receive Intravenous Pethidine and midazolam (20 to 40 milligram pethidine and 1 to 2 milligram midazolam) before beginning extracorporeal shock wave lithotripsy.
another group will receive Intravenous propofol and fentanyl (1.5 mg/ kg propofol and 1 Microgram / kg fentanyl) before beginning extracorporeal shock wave lithotripsy.

Sponsors

Vice Chancellor for research of Esfarayen University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Ability to read and write. Having consciousness in extent proper communication. No history of chronic use of narcotics and analgesics. No history of mental disorders. Age of 15-80 years old. Exclusion criteria: If the patient does not consent to be excluded. If deeper anesthesia and using other drugs is necessary. Having allergy to propofol, pethidine, midazolam or fentanyl.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: In the times of 15, 30, 45 and 60 minutes after Intervention. Method of measurement: Visual Pain Scale (VAS).

Secondary

MeasureTime frame
Satisfaction. Timepoint: After a full consciousness of the patient. Method of measurement: Using the checklist and self-report scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Kameli

North Khorasan University of Medical Sciences

ahmad_kamely@yahoo.com+98 58 3229 6909

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 18, 2026